Skip to content

Clinical trials

Thromboembolism trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Country / region: Switzerland Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20091
20123
20143
20151
20171
20182
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Terminated2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Insel Gruppe AG, University Hospital Bern2
University Hospital, Basel, Switzerland2
AstraZeneca1
Daiichi Sankyo1
Inari Medical1
Ottawa Hospital Research Institute1
Salah D. Qanadli1
Swiss Paraplegic Research, Nottwil1
University Hospital, Geneva1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism16
Pulmonary Embolism5
Venous Thromboembolism5
Venous Thrombosis5
Cardiovascular Diseases4
Thrombosis4
COVID-192
Embolism and Thrombosis2
Vascular Diseases2
Atherosclerosis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.